Report error Found 261 Enz. Inhib. hit(s) with all data for entry = 2323
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 1nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Hydra Biosciences
US Patent
Hydra Biosciences
US Patent
Affinity DataIC50: 2nMAssay Description:Compounds of Formula (I) inhibit the TRPA1 channel, as shown by measuring the in vitro inhibition of human TRPA1, provided in data tables shown in Ta...More data for this Ligand-Target Pair
















































